tm logo
CURADIGM
Live/Registered
REGISTERED

on 09 Jul 2019

Last Applicant/ Owned by

F-75012 PARIS

FR

Serial Number

79244477 filed on 01st Aug 2018

Registration Number

5796583 registered on 09th Jul 2019

in the Principal Register

Correspondent Address

Dreyfus & associés

78 avenue Raymond Poincaré

F-75116 PARIS, France

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CURADIGM

Color is not claimed as a feature of the mark. Products for medical use especially for metabolic pathways, namely, enzyme substrates and enzyme inhibitors; products for medical use especially for the diagnosis and treatment of tumors, namely, diagnostic preparation for medical purposes for the diagnosis of tumors and therapeutic pharmaceutical preparations for medical purposes for the treatment oRead More

Classification Information


Class [005]
Pharmaceutical Products


Products for medical use especially for metabolic pathways, namely, enzyme substrates and enzyme inhibitors; products for medical use especially for the diagnosis and treatment of tumors, namely, diagnostic preparation for medical purposes for the diagnosis of tumors and therapeutic pharmaceutical preparations for medical purposes for the treatment of tumors and rare hepatic diseases; preparations for medical use especially for modifying the bioavailability of therapeutic agents, namely, lipidic and polymeric formulation for drug delivery in the nature of drug delivery agents in the form of nanoparticles, nanovesicles, particles, vesicles, dissolvable films, coatings for tablets and hydrogels that facilitate the delivery of pharmaceutical preparations; preparations for medical use especially for modifying liver functions, namely, pharmaceutical preparations for the treatment of liver diseases and disorders and pharmaceutical preparations to alter hepatic metabolization pathways; preparations for medical use for modifying the functions of the reticuloendothelial system, namely, pharmaceutical preparations for the treatment of reticuloendothelial system diseases and disorders and pharmaceutical preparations to alter reticuloendothelial system endocytosis pathways; preparations made with nanomaterials for the delivery of therapeutic agents, namely, drug delivery agents in the form of enterally, parenterally in the nature of intravenous, or topically administered nanomaterials that facilitate the delivery of pharmaceutical preparations; chemical reagents for medical use; bacteriological preparations for medical use; biological preparations for medical use for the treatment of cancer, central nervous system disorders, cardiological, immunological, gastrointestinal, metabolic and infection diseases; enzymes for medical use; enzyme preparations for medical use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infection diseases; diagnostic products for medical use, namely, diagnostic preparations for medical purposes; drugs for medical use, namely, medical preparations for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infectious diseases; medicines for human medicine, namely, medical preparations for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infectious diseases; tonics medicines, namely, medical herbal preparations; antibiotics; antiseptics; chemico-pharmaceutical products for the treatment of the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infection diseases; pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; dietetic substances for medical use, namely, dietetic foods adapted for medical purposes; remedies for human medicine, namely, natural remedy preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalances, and sleep disorders

Class [010]
Medical Instrument Products


Surgical and medical apparatus and instruments especially for the diagnosis and treatment of tumors; Surgical and medical apparatus and instruments especially for monitoring and modifying metabolic functions; Apparatus for modifying the functions of the reticuloendothelial system, namely, medical apparatus and instruments for use in endovascular and cardiovascular procedures; Apparatus for modulating liver functions, namely, medical apparatus and instruments for use in measuring, quantifying and assessing liver health and oxygenation and perfusion apparatus in the nature of perfusion pumps for liver transplantation; Apparatus for the delivery of therapeutic or diagnostic agents, namely, medical apparatus and units for dosage, measuring and monitoring, in the nature of drug delivery devices and systems, and organ oxygenation and perfusion apparatus in the nature of perfusion pumps; Apparatus for modulating hepatic blood flow, namely, organ perfusion apparatus in the nature of perfusion pumps; Testing apparatus for medical use in the nature of medical diagnostic apparatus for testing cancer calls, DNA, organ oxygenation and blood sugar levels; Diagnostic apparatus for medical use for testing cancer calls, DNA, organ oxygenation and blood sugar levels

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, research and design especially in the field of nanomedicine, in the nature of nanotechnology applied to medicine; Biological research services; Bacteriological research services; Evaluations, estimates and research in scientific and technological fields provided by engineers and researchers, namely, conducting early evaluations in the field of new pharmaceuticals; Design and development of new products for third parties in the field of pharmaceutical preparations and diagnostic devices design; Technical research in the field of pharmaceutical project studies; Industrial analysis and research services, namely, biomedical research services; Chemical analysis; Chemical research; Chemistry services, namely, chemistry consultation; Surveying, namely, engineering work; Research and development of new products for others; Technical research in the field of pharmaceutical studies; Biological research, namely, radiobiology research, biological, pharmacokinetic, pharmacodynamic and immunological evaluation and toxicological evaluation; Medical research, namely, research in nanoscience and nanotechnology, especially applied to medicine

Class [044]
Medical, Beauty & Agricultural Services


Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy

Mark Details


Serial Number

No 79244477

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Feb 2020CHANGE OF OWNER RECEIVED FROM IB
15th Nov 2019FINAL DECISION TRANSACTION PROCESSED BY IB
29th Oct 2019FINAL DISPOSITION PROCESSED
29th Oct 2019FINAL DISPOSITION NOTICE SENT TO IB
09th Oct 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09th Jul 2019REGISTERED-PRINCIPAL REGISTER
03rd May 2019NOTIFICATION PROCESSED BY IB
23rd Apr 2019PUBLISHED FOR OPPOSITION
17th Apr 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17th Apr 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB